Estudio de algunos aspectos sobre las vacunas frente al SARS-CoV-2

  1. San-Miguel-Hernández, Ángel 12
  2. San-Miguel-Rodríguez, María
  1. 1 Sanidad de Castilla y León – SACYL. Hospital Universitario Río Hortega. Servicio de Análisis Clínicos. Valladolid, España
  2. 2 Universidad Internacional de La Rioja (UNIR). Logroño, España
Journal:
Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios

ISSN: 0304-4858,  2173-2302

Year of publication: 2021

Volume: 118

Issue: 3

Pages: 214-223

Type: Article

DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Gaceta médica de Bilbao: Revista oficial de la Academia de Ciencias Médicas de Bilbao. Información para profesionales sanitarios

Abstract

Once a vaccine is proven to be safe and effective, it must be approved by national regulatory authorities and manufactured to precise standards and distributed.WHO is collaborating with all countries of the world to help coordinate the key stages of this vaccine manufacturing and development process. In particular to facilitate equitable access to vaccines against Covid-19 and that are safe and effective for the billions of people who need them. Here are still many unknowns that arise about the pandemic caused by SARS-COV-2 and about vaccines. This article tries to see some of the unknowns that arise with respect to them.

Data source: Dialnet